KBH vs MHO

KB Home exhibits a strong deterministic health profile with a Piotroski F-Score of 8/9, indicating robust operational efficiency and financial stability. While the stock is fundamentally undervalued from a defensive standpoint (Graham Number: $84.69, P/B: 0.88), it is currently battling a severe cyclical downturn characterized by a 65% drop in YoY earnings and a 22.6% decline in revenue. The divergence between the high Graham Number and the low growth-based intrinsic value ($36.26) highlights a conflict between asset value and current earnings momentum. Consequently, the stock is a value play with significant headwinds in growth and technical sentiment.

MHO exhibits a strong deterministic health profile with a Piotroski F-Score of 7/9 and an exceptionally liquid balance sheet (Current Ratio 7.91). While the stock is significantly undervalued relative to its Graham Number ($193.29) and trades at a low P/E of 9.77, these value drivers are offset by severe fundamental decay. Year-over-year earnings have plummeted by 35.9%, and insider sentiment is heavily bearish with consistent selling from the CEO and CFO. The company is currently a 'value trap' candidate: fundamentally healthy and cheap, but lacking growth catalysts and internal confidence.